GLS and cancer: The robust enzymatic activity of the GLS1-GAC isoform enables tumour cells to channel greater amounts of glutamine into the TCA cycle, thereby enhancing the proliferative capacity of the cancer cells and driving more aggressive cellular behaviour [25].